Univariate comparison of performance of different cerebrovascular reactivity indices for outcome association in adult TBI: a CENTER-TBI study.


Journal

Acta neurochirurgica
ISSN: 0942-0940
Titre abrégé: Acta Neurochir (Wien)
Pays: Austria
ID NLM: 0151000

Informations de publication

Date de publication:
06 2019
Historique:
received: 28 11 2018
accepted: 12 02 2019
pubmed: 17 3 2019
medline: 14 4 2020
entrez: 17 3 2019
Statut: ppublish

Résumé

Monitoring cerebrovascular reactivity in adult traumatic brain injury (TBI) has been linked to global patient outcome. Three intra-cranial pressure (ICP)-derived indices have been described. It is unknown which index is superior for outcome association in TBI outside previous single-center evaluations. The goal of this study is to evaluate indices for 6- to 12-month outcome association using uniform data harvested in multiple centers. Using the prospectively collected data from the Collaborative European NeuroTrauma Effectiveness Research in TBI (CENTER-TBI) study, the following indices of cerebrovascular reactivity were derived: PRx (correlation between ICP and mean arterial pressure (MAP)), PAx (correlation between pulse amplitude of ICP (AMP) and MAP), and RAC (correlation between AMP and cerebral perfusion pressure (CPP)). Univariate logistic regression models were created to assess the association between vascular reactivity indices with global dichotomized outcome at 6 to 12 months, as assessed by Glasgow Outcome Score-Extended (GOSE). Models were compared via area under the receiver operating curve (AUC) and Delong's test. Two separate patient groups from this cohort were assessed: the total population with available data (n = 204) and only those without decompressive craniectomy (n = 159), with identical results. PRx, PAx, and RAC perform similar in outcome association for both dichotomized outcomes, alive/dead and favorable/unfavorable, with RAC trending towards higher AUC values. There were statistically higher mean values for the index, % time above threshold, and hourly dose above threshold for each of PRx, PAx, and RAC in those patients with poor outcomes. PRx, PAx, and RAC appear similar in their associations with 6- to 12-month outcome in moderate/severe adult TBI, with RAC showing tendency to achieve stronger associations. Further work is required to determine the role for each of these cerebrovascular indices in monitoring of TBI patients.

Sections du résumé

BACKGROUND
Monitoring cerebrovascular reactivity in adult traumatic brain injury (TBI) has been linked to global patient outcome. Three intra-cranial pressure (ICP)-derived indices have been described. It is unknown which index is superior for outcome association in TBI outside previous single-center evaluations. The goal of this study is to evaluate indices for 6- to 12-month outcome association using uniform data harvested in multiple centers.
METHODS
Using the prospectively collected data from the Collaborative European NeuroTrauma Effectiveness Research in TBI (CENTER-TBI) study, the following indices of cerebrovascular reactivity were derived: PRx (correlation between ICP and mean arterial pressure (MAP)), PAx (correlation between pulse amplitude of ICP (AMP) and MAP), and RAC (correlation between AMP and cerebral perfusion pressure (CPP)). Univariate logistic regression models were created to assess the association between vascular reactivity indices with global dichotomized outcome at 6 to 12 months, as assessed by Glasgow Outcome Score-Extended (GOSE). Models were compared via area under the receiver operating curve (AUC) and Delong's test.
RESULTS
Two separate patient groups from this cohort were assessed: the total population with available data (n = 204) and only those without decompressive craniectomy (n = 159), with identical results. PRx, PAx, and RAC perform similar in outcome association for both dichotomized outcomes, alive/dead and favorable/unfavorable, with RAC trending towards higher AUC values. There were statistically higher mean values for the index, % time above threshold, and hourly dose above threshold for each of PRx, PAx, and RAC in those patients with poor outcomes.
CONCLUSIONS
PRx, PAx, and RAC appear similar in their associations with 6- to 12-month outcome in moderate/severe adult TBI, with RAC showing tendency to achieve stronger associations. Further work is required to determine the role for each of these cerebrovascular indices in monitoring of TBI patients.

Identifiants

pubmed: 30877472
doi: 10.1007/s00701-019-03844-1
pii: 10.1007/s00701-019-03844-1
pmc: PMC6525666
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1217-1227

Investigateurs

Audny Anke (A)
Ronny Beer (R)
Bo-Michael Bellander (BM)
Andras Buki (A)
Giorgio Chevallard (G)
Arturo Chieregato (A)
Giuseppe Citerio (G)
Endre Czeiter (E)
Bart Depreitere (B)
George Eapen (G)
Shirin Frisvold (S)
Raimund Helbok (R)
Stefan Jankowski (S)
Daniel Kondziella (D)
Lars-Owe Koskinen (LO)
Geert Meyfroidt (G)
Kirsten Moeller (K)
David Nelson (D)
Anna Piippo-Karjalainen (A)
Andreea Radoi (A)
Arminas Ragauskas (A)
Rahul Raj (R)
Jonathan Rhodes (J)
Saulius Rocka (S)
Rolf Rossaint (R)
Juan Sahuquillo (J)
Oliver Sakowitz (O)
Ana Stevanovic (A)
Nina Sundström (N)
Riikka Takala (R)
Tomas Tamosuitis (T)
Olli Tenovuo (O)
Peter Vajkoczy (P)
Alessia Vargiolu (A)
Rimantas Vilcinis (R)
Stefa Wolf (S)
Alexander Younsi (A)

Commentaires et corrections

Type : CommentIn
Type : ErratumIn

Références

Neurosurgery. 2015 Jan;76(1):67-80
pubmed: 25525693
J Neurotrauma. 2017 Mar 1;34(5):963-970
pubmed: 27246184
J Neurotrauma. 2018 May 15;35(10):1107-1115
pubmed: 29241396
Stroke. 2008 Sep;39(9):2531-7
pubmed: 18669896
Neurosurgery. 1997 Jul;41(1):11-7; discussion 17-9
pubmed: 9218290
J Trauma Acute Care Surg. 2013 Feb;74(2):639-46
pubmed: 23354263
Neurocrit Care. 2012 Aug;17(1):67-76
pubmed: 22477613
Acta Neurochir (Wien). 2018 Jul;160(7):1315-1324
pubmed: 29732476
Acta Neurochir Suppl. 2016;122:245-8
pubmed: 27165915
J Neurosurg. 2014 Jun;120(6):1451-7
pubmed: 24745709
Neurosurgery. 2017 Jan 01;80(1):6-15
pubmed: 27654000
J Neurotrauma. 2018 Dec 1;35(23):2812-2819
pubmed: 29808745
Neurocrit Care. 2014 Dec;21 Suppl 2:S282-96
pubmed: 25501689
J Clin Monit Comput. 2015 Feb;29(1):97-105
pubmed: 24664812
J Neurotrauma. 2017 Dec 1;34(23):3224-3237
pubmed: 28699412
Neurocrit Care. 2012 Apr;16(2):258-66
pubmed: 21964774
J Appl Physiol (1985). 2013 Jul 1;115(1):52-6
pubmed: 23681909
Int J Epidemiol. 2017 Oct 1;46(5):1372-1378
pubmed: 29025122
Crit Care Med. 2016 Oct;44(10):e996-9
pubmed: 27270178
J Neurotrauma. 2018 Feb 9;:
pubmed: 29212405
Neurocrit Care. 2014 Dec;21 Suppl 2:S95-102
pubmed: 25208679
Crit Care Med. 2012 Aug;40(8):2456-63
pubmed: 22622398
J Neurotrauma. 2018 Dec 1;35(23):2803-2811
pubmed: 29978744

Auteurs

Frederick A Zeiler (FA)

Division of Anaesthesia, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK. umzeiler@myumanitoba.ca.
Department of Surgery, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, R3A 1R9, Canada. umzeiler@myumanitoba.ca.
Clinician Investigator Program, Rady Faculty of Health Science, University of Manitoba, Winnipeg, MB, Canada. umzeiler@myumanitoba.ca.
Brain Physics Laboratory, Division of Neurosurgery, Dept of Clinical Neurosciences, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK. umzeiler@myumanitoba.ca.

Ari Ercole (A)

Division of Anaesthesia, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.

Manuel Cabeleira (M)

Brain Physics Laboratory, Division of Neurosurgery, Dept of Clinical Neurosciences, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.

Tommaso Zoerle (T)

Neuro ICU Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.

Nino Stocchetti (N)

Neuro ICU Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.
Department of physiopathology and transplantation, Milan University, Milan, Italy.

David K Menon (DK)

Division of Anaesthesia, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.
Neurosciences Critical Care Unit, Addenbrooke's Hospital, Cambridge, England.
Queens' College, Cambridge, England.
National Institute for Health Research, London, UK.

Peter Smielewski (P)

Brain Physics Laboratory, Division of Neurosurgery, Dept of Clinical Neurosciences, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.

Marek Czosnyka (M)

Brain Physics Laboratory, Division of Neurosurgery, Dept of Clinical Neurosciences, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.
Institute of Electronic Systems, Warsaw University of Technology, Warsaw, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH